Home › Griffin Securities Reiterates $95.00 Price Target for Ligand Pharmaceuticals
 

Keywords :   


Griffin Securities Reiterates $95.00 Price Target for Ligand Pharmaceuticals

2014-09-27 08:07:22| Biotech - Topix.net

Griffin Securities' price objective points to a potential upside of 98.25% from the company's current price. A number of other firms have also recently commented on LGND.

Tags: price target securities griffin

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
More »